BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 27
• 28
• 29

• Business

  Boehringer Ingelheim Corporation Sets $91 Million Shanghai Expansion

  December 15, 2011

   · 

  1 min read
• Genetown

  Cerulean Pharma Inc. Closes $15 Million Series D Financing

  December 15, 2011

   · 

  2 min read
• Drug Development

  Successful Completion of Hatchtech’s Phase 2b Clinical Trial in Head Lice

  December 15, 2011

   · 

  4 min read
• Policy

  Vertex Pharmaceuticals Incorporated Release: FDA Grants Priority Review for KALYDECO™ (ivacaftor), the First Potential Medicine to Target the Underlying Cause of Cystic Fibrosis

  December 15, 2011

   · 

  1 min read
• BioCapital

  CAS Medical Systems, Inc. Completes $20.5 Million Series B Financing

  December 15, 2011

   · 

  2 min read
• Business

  Covidien plc Plans Spin-off of Pharmaceuticals Business

  December 15, 2011

   · 

  6 min read
• Bio NC

  TransEnterix Raises $15 Million; ‘SPIDER’ Device Makes Surgery Less Invasive

  December 15, 2011

   · 

  1 min read
• Successful North American Product Launch Prompts SAW Instruments GmbH to Extend sam®X Early Adopter Price Promotion

  December 15, 2011

   · 

  2 min read
• Drug Development

  Catalyst Pharmaceutical Partners, Inc. Release: Scientific Paper Regarding CPP-115 for the Treatment of Cocaine Addiction Accepted for Publication in the Journal of Medicinal Chemistry

  December 15, 2011

   · 

  1 min read
• Bio NC

  Chelsea Therapeutics, Inc. Receives Notice of Allowance of Key U.S. Patent for Novel, Controlled Release Formulation of Northera(TM)

  December 15, 2011

   · 

  1 min read